Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Summary

This study will evaluate the long-term safety of botulinum toxin type A for the treatment of moderate to severe crow's feet lines after repeat application.

Timeline

Start

2013-02

Primary completion

2013-07

Completion

2013-12

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision to terminate study (not due to safety reasons)”

Drugs

Indications